Norepinephrine-and epinephrine-induced distinct β2-Adrenoceptor signaling is dictated by GRK2 phosphorylation in cardiomyocytes

被引:56
作者
Wang, Yongyu [1 ]
De Arcangelis, Vania [1 ]
Gao, Xiaoguang [1 ]
Ramani, Biswarathan [1 ]
Jung, Yi-Sook [1 ]
Xiang, Yang [1 ]
机构
[1] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61822 USA
关键词
D O I
10.1074/jbc.M705747200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Agonist-dependent activation of G protein-coupled receptors induces diversified receptor cellular and signaling properties. Norepinephrine (NE) and epinephrine (Epi) are two endogenous ligands that activate adrenoceptor (AR) signals in a variety of physiological stress responses in animals. Here we use cardiomyocyte contraction rate response to analyze the endogenous beta(2)AR signaling induced by Epi or NE in cardiac tissue. The Epi-activated beta(2)AR induced a rapid contraction rate increase that peaked at 4 min after stimulation. In contrast, the NE-activated beta(2)AR induced a much slower contraction rate increase that peaked at 10 min after stimulation. Whereas both drugs activated beta(2)AR coupling to G(s) proteins, only Epi-activated receptors were capable of coupling to G(i) proteins. Subsequent studies showed that the Epi-activated beta(2)AR underwent a rapid phosphorylation by G protein-coupled receptor kinase 2 (GRK2) and subsequent dephosphorylation on serine residues 355 and 356, which was critical for sufficient receptor recycling and Gi coupling. In contrast, the NE-activated beta(2)ARs underwent slow GRK2 phosphorylation, receptor internalization and recycling, and failed to couple to Gi. Moreover, inhibiting beta(2)AR phosphorylation by beta ARK C terminus or dephosphorylation by okadaic acid prevented sufficient recycling and Gi coupling. Together, our data revealed that distinct temporal phosphorylation of beta(2)AR on serine 355 and 356 by GRK2 plays a critical role for dictating receptor cellular events and signaling properties induced by Epi or NE in cardiomyocytes. This study not only helps us understand the endogenous agonist-dependent beta(2)AR signaling in animal heart but also offers an example of how G protein-coupled receptor signaling may be finely regulated by GRK in physiological settings.
引用
收藏
页码:1799 / 1807
页数:9
相关论文
共 39 条
[1]   β-Arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors [J].
Azzi, M ;
Charest, PG ;
Angers, S ;
Rousseau, G ;
Kohout, T ;
Bouvier, M ;
Piñeyro, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (20) :11406-11411
[2]   Conformational changes of G protein-coupled receptors during their activation by agonist binding [J].
Bissantz, C .
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2003, 23 (2-3) :123-153
[3]   Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure [J].
Bristow, MR ;
Gilbert, EM ;
Abraham, WT ;
Adams, KF ;
Fowler, MB ;
Hershberger, RE ;
Kubo, SH ;
Narahara, KA ;
Ingersoll, H ;
Krueger, S ;
Young, S ;
Shusterman, N .
CIRCULATION, 1996, 94 (11) :2807-2816
[4]  
BRISTOW MR, 1989, MOL PHARMACOL, V35, P295
[5]   Mechanism of beta-adrenergic receptor desensitization in cardiac hypertrophy is increased beta-adrenergic receptor kinase [J].
Choi, DJ ;
Koch, WJ ;
Hunter, JJ ;
Rockman, HA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (27) :17223-17229
[6]   Long-acting β2-agonists in asthma -: Not so SMART? [J].
Currie, Graeme P. ;
Lee, Daniel K. C. ;
Lipworth, Brian J. .
DRUG SAFETY, 2006, 29 (08) :647-656
[7]  
Devic E, 2001, MOL PHARMACOL, V60, P577
[8]  
Eglen RM, 2005, P W PHARMACOL SOC, V48, P31
[9]   Seminars in medicine of the Beth Israel Hospital, Boston - Adrenergic receptors - Evolving concepts and clinical implications [J].
Flier, J ;
Insel, PA .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (09) :580-585
[10]   Genetic manipulation of myocardial β-adrenergic receptor activation and desensitization [J].
Hata, JA ;
Williams, ML ;
Koch, WJ .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2004, 37 (01) :11-21